Physician profile
Omar Aly
NPI 1265724389
$1,141.53
in general payments reported to CMS, 2019-2025
17 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.96 · 2020: $20.34 · 2021: $81.27 · 2022: $13.27 · 2023: $89.20 · 2024: $660 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988 · Education: $15.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.72 |
| Education | $15.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $224.39 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $187.54 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $96.19 | 2024 | Dificid |
| Glaxosmithkline, LLC. | $85.61 | 2020-2024 | Benlysta |
| Novartis Pharmaceuticals Corporation | $80.89 | 2019-2024 | |
| Abbvie INC. | $65.97 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $64.59 | 2024 | Eliquis |
| Actelion Pharmaceuticals US, INC. | $55.51 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.13 | 2025 | Lifevest |
| Verona Pharma, INC. | $46.14 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.44 | 2024 | Jardiance |
| Shionogi INC | $35.72 | 2023-2024 | Fetroja |
| Aimmune Therapeutics, INC. | $23.01 | 2024 | |
| Cytovale, INC. | $21.26 | 2025 | |
| Boston Scientific Corporation | $19.78 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $19.39 | 2024 | Veklury |
| Celltrion USA INC. | $15.97 | 2023 | Yuflyma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Aly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.